Search Results

Filter
  • 1-10 of  477 results for ""Adverse Drug Reaction Reporting Systems""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Post-marketing safety concerns with palbociclib: a disproportionality analysis of the FDA adverse event reporting system.

  • Authors : Cheng Q; Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Shi X

Subjects: Pyridines*/Pyridines*/Pyridines*/adverse effects ; Pyridines*/Pyridines*/Pyridines*/administration & dosage ; Piperazines*/Piperazines*/Piperazines*/adverse effects

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 May; Vol. 23 (5), pp. 637-648. Date of Electronic Publication: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Danish post-marketing pharmacosurveillance of spontaneous Oral Adverse Drug Reactions 2009-2019.

  • Authors : Ellefsen BS; Section of Oral Pathology and Medicine, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Larsen KR

Subjects: Product Surveillance, Postmarketing* ; Adverse Drug Reaction Reporting Systems* ; Drug-Related Side Effects and Adverse Reactions*

  • Source: Oral diseases [Oral Dis] 2024 Apr; Vol. 30 (3), pp. 1573-1582. Date of Electronic Publication: 2023 Apr 27.Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9508565 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1601-0825

Record details

×
Academic Journal

Bayesian safety surveillance with adaptive bias correction.

  • Authors : Bu F; Department of Biostatistics, University of California, Los Angeles, California, USA.; Department of Biostatistics, University of Michigan-Ann Arbor, Ann Arbor, Michigan, USA.

Subjects: Adverse Drug Reaction Reporting Systems* ; Vaccines*/Vaccines*/Vaccines*/adverse effects ; Product Surveillance, Postmarketing*

  • Source: Statistics in medicine [Stat Med] 2024 Jan 30; Vol. 43 (2), pp. 395-418. Date of Electronic Publication: 2023 Nov 27.Publisher: Wiley Country of Publication: England NLM ID: 8215016 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0258

Record details

×
Academic Journal

Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients.

  • Authors : Kanbayashi Y; Department of Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan. .; Tsuchiya E

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Product Surveillance, Postmarketing* ; Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/adverse effects

  • Source: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences [Daru] 2024 Jun; Vol. 32 (1), pp. 279-287. Date of Electronic Publication: 2024 Apr 26.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101125969 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Post-marketing surveillance of 10,392 herpes zoster vaccines doses in Australia.

  • Authors : Muttucumaru R; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Australia; National Centre for Epidemiology and Population Health, College of Health & Medicine, The Australian National University, Canberra, Australia.

Subjects: Herpes Zoster Vaccine*/Herpes Zoster Vaccine*/Herpes Zoster Vaccine*/adverse effects ; Herpes Zoster Vaccine*/Herpes Zoster Vaccine*/Herpes Zoster Vaccine*/administration & dosage ; Herpes Zoster Vaccine*/Herpes Zoster Vaccine*/Herpes Zoster Vaccine*/immunology

  • Source: Vaccine [Vaccine] 2024 May 10; Vol. 42 (13), pp. 3166-3171. Date of Electronic Publication: 2024 Apr 25.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Postmarket safety communications on drugs approved in Japan: A 25-year analysis.

  • Authors : Tanaka Y; Clinical and Translational Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.; Tanaka M

Subjects: Drug Approval* ; Product Surveillance, Postmarketing*/Product Surveillance, Postmarketing*/Product Surveillance, Postmarketing*/statistics & numerical data ; Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/epidemiology

  • Source: Clinical and translational science [Clin Transl Sci] 2024 Apr; Vol. 17 (4), pp. e13803.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Post-marketing surveillance study on influenza vaccine in South Korea using a nationwide spontaneous reporting database with multiple data mining methods.

  • Authors : Lee H; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon-si, Gyeonggi-do, 16419, South Korea.; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.

Subjects: Data Mining* ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/adverse effects ; Product Surveillance, Postmarketing*

  • Source: Scientific reports [Sci Rep] 2022 Nov 24; Vol. 12 (1), pp. 20256. Date of Electronic Publication: 2022 Nov 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Machine Learning Approach for Active Vaccine Safety Monitoring.

  • Authors : Kim Y; Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Yongin, Korea.; Jang JH

Subjects: Adverse Drug Reaction Reporting Systems* ; Machine Learning* ; Product Surveillance, Postmarketing*

  • Source: Journal of Korean medical science [J Korean Med Sci] 2021 Aug 09; Vol. 36 (31), pp. e198. Date of Electronic Publication: 2021 Aug 09.Publisher: Korean Academy of Medical Science Country of Publication: Korea (South) NLM ID: 8703518 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Analysis of completeness for spontaneous reporting of disease-modifying therapies in multiple sclerosis.

  • Authors : Araujo AGS; Pharmaceutical Sciences Postgraduate Research Program, Health Sciences Sector, Federal University of Paraná, Curitiba, Brazil.; Lucchetta RC

Subjects: Adverse Drug Reaction Reporting Systems/Adverse Drug Reaction Reporting Systems/Adverse Drug Reaction Reporting Systems/*statistics & numerical data ; Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*epidemiology ; Multiple Sclerosis/Multiple Sclerosis/Multiple Sclerosis/*drug therapy

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2021 Jun; Vol. 20 (6), pp. 735-740. Date of Electronic Publication: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.

  • Authors : Chen G; Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.; Ning LJ

Subjects: Adverse Drug Reaction Reporting Systems*; Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*chemically induced ; Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*epidemiology

  • Source: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2021 Jan; Vol. 36 (1), pp. 156-162. Date of Electronic Publication: 2020 Jul 03.Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  477 results for ""Adverse Drug Reaction Reporting Systems""